Overview

A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

Status:
No longer available
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit. Assessments of safety and tolerability of maraviroc when added to OBT will be continued.
Details
Lead Sponsor:
ViiV Healthcare
Collaborator:
Pfizer
Treatments:
Maraviroc